InvestorsHub Logo
icon url

Rustmore

02/17/21 5:59 PM

#1334 RE: nealhugh #1332

Finished at $0.25 today after $55K in buys and $45K in sells. It could have been a fairly flat day at $0.20 close - a couple of small buys in the last 5 mins saved the narrative for the day.

In other words, there is a lot of selling as the price slowly goes up, and the % increase that is recorded for the day may come down to the luck of the draw in the last 5 mins.

Devil's in the details.

icon url

FairviewInvestor

02/17/21 8:10 PM

#1336 RE: nealhugh #1332

Excellent Neil, I still like the recommendation I gave you on SEELOS Therapeutics.

Ketamine is very much still under the radar for most US investors. It's a very strong med and Johnson&Johnson's strangle hold on the scripts will come to an end. I'm watching for $2.90-$3.40 and will probably buy back in. I've made 4 round trips on it in the last 2 months for over $20K in profits. big gainer ;)

patient trials are due in April/May.

my only concern with a buy & hold strategy is a secondary raise, even though they just did one... pharmas love to grab money when it's sitting on the table.... ramping up for commercialization is pricey

This will be trading $5-$10 soon enough. either before or after data on patient trials

** for others, sorry to post on here, I can't send Private Messages